OBIO Orchestra BioMed Holdings, Inc.
Healthcare$3.97-2.22%ClosedMarket Cap: $237.7M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$13.00
Target (Median)
$13.00
Target Range
$13.00 - $13.00
Upside from current price: 227.5%
Rating Distribution
2 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-19 | B. Riley Securities | maintain | Buy | Buy |
| 2026-05-14 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-13 | Barclays | maintain | Overweight | Overweight |
| 2026-03-12 | Chardan Capital | maintain | Buy | Buy |
| 2026-01-09 | Barclays | maintain | Overweight | Overweight |
| 2025-11-13 | Chardan Capital | maintain | Buy | Buy |
| 2025-11-12 | Barclays | maintain | Overweight | Overweight |
| 2025-09-04 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-20 | BTIG | downgrade | Neutral | Buy |
| 2025-08-13 | Chardan Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.39 | $655.4K | 6 |
| Sun Dec 31 | $-0.96 | $14.8M | 3 |
| Mon Dec 31 | $-0.27 | $53.6M | 1 |
| Tue Dec 31 | $0.33 | $111.2M | 1 |